Teva to Acquire the Generics Activities of Allergan for Over $40 Billion

30.07.2015 - In the latest spectacular takeover to occupy the attention of the international pharmaceuticals sector, Israeli generics giant Teva has agreed to pay $40.5 billion cash and stock...